Advanced biliary tract cancer represents one of the most challenging gastrointestinal malignancies in China, with increasing incidence and extremely poor prognosis due to late-stage diagnosis and ...

SEOUL, South Korea, Dec. 23, 2025 /PRNewswire/ -- Lunit (KRX: 328130) , a leading provider of AI for cancer diagnostics and precision oncology, today announced that a new study evaluating its ...

Researchers find that FOLFIRINOX, a chemotherapy used for pancreatic cancer, may improve survival in advanced biliary tract cancer patients BUSAN, South Korea, Nov. 28, 2025 /PRNewswire/ -- A new ...

Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the ...

The Atlantic Meridional Overturning Circulation (AMOC), an ocean current system that transports heat from the tropics to the North Atlantic, plays a vital role in regulating the global climate. Most ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Denver-based Tract is doubling ...

Biliary atresia is a rare liver disease where bile ducts become blocked, leading to rapid liver damage in infants. Early diagnosis, ideally within the first 60 days of life, is the single most ...

The Atlantic Meridional Overturning Circulation (AMOC) is an enormous loop of ocean current in the Atlantic Ocean that carries warmer waters north and colder waters south, helping to regulate the ...

HONG KONG, Sept. 2, 2025 /PRNewswire/ -- Akeso (9926.HK) has recently announced the completion of patient enrollment in its Phase III, multicenter, randomized, controlled, registrational study ...

Chinese patients with resectable biliary tract cancers treated with adjuvant camrelizumab plus concurrent capecitabine and radiotherapy were compared with patients on observation. Overall survival at ...

FDA designates FF-10832 as an orphan drug for biliary tract cancer, promising enhanced treatment options for this aggressive malignancy. The FDA has granted orphan drug designation to FF-10832 ...